Institutional shares held 638,859
0 calls
0 puts
Total value of holdings $300K
$0 calls
$0 puts
Market Cap $3.88M
8,258,600 Shares Out.
Institutional ownership 7.74%
# of Institutions 20


Latest Institutional Activity in INDP

Top Purchases

Q1 2025
Sbi Securities Co., Ltd. Shares Held: 4.4K ($2.07K)
Q4 2024
Susquehanna International Group, LLP Shares Held: 17.8K ($8.38K)
Q4 2024
Two Sigma Securities, LLC Shares Held: 16.6K ($7.81K)
Q4 2024
Geode Capital Management, LLC Shares Held: 82.1K ($38.6K)
Q4 2024
Ubs Group Ag Shares Held: 2.52K ($1.19K)

Top Sells

Q1 2025
Bangor Savings Bank Shares Held: 350 ($165)
Q4 2024
Tower Research Capital LLC (Trc) Shares Held: 3.51K ($1.65K)
Q4 2024
Pine Valley Investments LTD Liability CO Shares Held: 43.9K ($20.6K)
Q3 2024
Citadel Advisors LLC Shares Held: 15.4K ($7.23K)
Q2 2024
Wells Fargo & Company Shares Held: 64 ($30.1)

About INDP

Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.


Insider Transactions at INDP

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
127K Shares
From 1 Insiders
Grant, award, or other acquisition 127K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on INDP

Follow Indaptus Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INDP shares.

Notify only if
Any

Insider Trading

Get notified when an Indaptus Therapeutics, Inc. insider buys or sells INDP shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Indaptus Therapeutics, Inc.

Track Activities on INDP